Anecdotal or experimental: how does published safety evidence affect self-reported willingness of avian veterinarians to use certain drugs in clinical practice?

Avian veterinarians weight controlled experimental studies more heavily than adverse drug event case series when making prescribing decisions.

This study investigated how avian veterinarians interpret and incorporate published safety evidence of varying methodological quality into their clinical decision-making. Members of the American Association of Zoo Veterinarians and the European Association of Zoo and Wildlife Veterinarians were electronically surveyed regarding their willingness to use two drugs—polysulfated glycosaminoglycan (PSGAG) and voriconazole—in avian patients. Participants were assessed before and after reading adverse drug event (ADE) case series and subsequently published controlled experimental studies (CES) for each drug. Results demonstrated that willingness to use voriconazole increased from 77.6% after reading the ADE series to 94.3% after the CES, while willingness to use PSGAG rose dramatically from 35.7% to 69.0% following the CES. A substantial majority of respondents (75.5% for voriconazole; 69.0% for PSGAG) identified the CES as more impactful in shaping their overall clinical opinion compared to ADE case series. These findings highlight that avian clinicians appropriately weight higher-tier experimental evidence more heavily than anecdotal case reports when making prescribing decisions. The authors emphasize that controlled experimental studies represent superior levels of evidence and are critical for advancing evidence-based medicine in zoological and avian practice. The study underscores the importance of producing high-quality experimental research to challenge existing clinical dogmas, improve drug safety assessments, and ultimately enhance patient care in exotic animal medicine.

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.